TechNavio today launched its report Spinal Devices and Biologics Market in the US 2011-2015 based on an in-depth study exclusively focusing on the US. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; ”The latest trends in the Spinal Devices and Biologics market in the US are expected to help the market to sustain its growth rate. One such trend is the developments being made in the field of spinal implants. The replacement of metals by human tissue scaffolds is gaining popularity, and the use of nanotechnology and tissue engineering is on the rise.”
According to the report, globally, the main driver for this market is the increase in the aging population in the US. Lower mortality rates, increased life expectancy, and birth control in the US have resulted in an increase in the aging population, which is likely to increase by 2015. This will result in an increase in spinal surgeries, thereby increasing the demand for spinal devices and propelling the growth of the Spinal Devices and Biologics market in the US.
Further, the report also discusses that the shortage of qualified spinal surgeons in the US is a major challenge for the Spinal Devices and Biologics market in the US.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/spinal-devices-and-biologics-market-us-…
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report – Spinal Devices and Biologics Market in the US 2011-2015
